Skip to content

Study on the efficacy and safety of ciprofol compared to propofol during hysteroscopy

Study on the efficacy and safety of ciprofol compared to propofol during hysteroscopy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066674
Enrollment
Unknown
Registered
2022-12-13
Start date
2022-07-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anesthesia in hysteroscopy

Interventions

Sponsors

Heyuan People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ?Women patients scheduled for hysteroscopy; ?The subjects were aged 18 to 65 years old and classified as I - II by ASA; ?The body mass index (BMI) of 18-30 kg/m2; ?Respiration?rate (RR) 10-24 breaths/min, pulse oxygen?saturation (SPO2) =95%, systolic blood pressure (SBP) 85–140 mmHg and diastolic blood pressure (DBP) 50-90 mmHg, heart rate (HR) 50-100 beats/min (bpm); ?No contraindications for hysteroscopic surgery and sedation/general anesthesia

Exclusion criteria

Exclusion criteria: ?History of alcohol; ?History of general anesthetic allergy; ?Long-term?use of sedative-hypnotics and anti-anxiety drugs; ?History of unregulated or malignant hypertension; ?Severe ischemic heart diseases or renal or liver dysfunction; ?Pregnancy or ?lactation; ?Recent respiratory tract infection; ?Nervous system diseases or mental disorders with communication difficulties.

Design outcomes

Primary

MeasureTime frame
success rate of anesthesia ;

Secondary

MeasureTime frame
the onset?time of?anesthesia;time to being fully alert;time out of the operating room;the?per?capita dosage of study drugs;the rate of occurrence of adverse events;Body movement;injection pain evaluation;vital signs at different time points;evaluation of satisfaction;postoperative?complications;

Countries

China

Contacts

Public ContactGuiling Xie

Heyuan People’s Hospital

0821xgl@sina.com17818050990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026